Release Date: February 9, 2026
Expiration Date: March 16, 2026
Activity Overview
This educational activity is an archive of the live presentation held on January 25, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancers and breast cancers. Other health care professionals interested in the treatment of these malignancies are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate biomarkers, genomic assays, and other molecular testing tools into the development of personalized treatment plans for patients with breast cancer
- Assess clinical trial evidence for current and emerging systemic therapies for use in the management of early-stage and advanced/metastatic breast cancer
- Develop individualized treatment plans for patients with early-stage and advanced/metastatic breast cancer by incorporating high-level clinical trial evidence with tumor- and patient-specific factors
- Develop strategies to minimize or prevent treatment-related AEs in patients receiving treatment for breast cancer to improve adherence and patient outcomes
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
